ID   DLKP-A
AC   CVCL_H741
DR   Wikidata; Q54831173
RX   PubMed=1369413;
RX   PubMed=19242932;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
RX   PubMed=1369413; DOI=10.1007/BF00376102;
RA   Clynes M., Redmond A., Moran E., Gilvarry U.;
RT   "Multiple drug-resistance in variant of a human non-small cell lung
RT   carcinoma cell line, DLKP-A.";
RL   Cytotechnology 10:75-89(1992).
//
RX   PubMed=19242932; DOI=10.1002/pmic.200800633;
RA   Keenan J., Murphy L., Henry M., Meleady P., Clynes M.;
RT   "Proteomic analysis of multidrug-resistance mechanisms in
RT   adriamycin-resistant variants of DLKP, a squamous lung cancer cell
RT   line.";
RL   Proteomics 9:1556-1566(2009).
//